Market Tracker

01/20 5:16pm ET

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

5.25
Delayed Data
As of Jan 20
 -0.08 / -1.50%
Today’s Change
3.05
Today|||52-Week Range
9.72
-0.76%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close5.33
Today’s open5.29
Day’s range5.10 - 5.29
Volume25,983
Average volume (3 months)185,665
Market cap$22.7M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+49.44%
Earnings growth (this year)+27.96%
Earnings growth (next 5 years)--
Revenue growth (last year)+12.11%
P/E ratioNM
Price/Sales8.37
Price/Book0.84

Competitors

 Today’s
change
Today’s
% change
TKAITokai Pharmaceutical...-0.02-1.93%
MRNSMarinus Pharmaceutic...0.000.00%
PRANPrana Biotechnology ...-0.09-3.47%
ABIOARCA Biopharma Inc+0.15+5.88%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 29, 2017
EPS forecast (this quarter)-$0.89
Annual revenue (last year)$1.9M
Annual profit (last year)-$14.3M
Net profit margin-737.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts